North West | Industry, manufacturing | Finance, business

Rusnano and Kaliningrad shake hands on nano-cooperation

10 Dec '12
Russias westernmost enclave of Kaliningrad and Rusnano, this countrys largest nanotech company, outlined last week the main areas of cooperation in innovation and ways of implementing nanotech projects in the region, both with or without Rusnano participation, the official website of the Kaliningrad regional government reports.

At the meeting, the region was represented by the local Ministry of Industrial Policy and the Development of Entrepreneurship and Commerce as well as some top managers of the Kaliningrad Regional Development Corporation.

The partners discussed some practical measures that would provide the fast track for regional nanotech projects in finding premises and industrial sites. The region promised to back such companies and offer them preferential treatment.

Rusnano and the Kaliningrad region also strategized steps in supporting local companies that seek co-funding from Rusnano.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
COMMENT ON THIS STORY
Find Related Content
Latest News: North West
11 Mar '15 | Technology & innovation
27 Feb '15 | Energy, utilities | Technology & innovation
24 Feb '15 | Retail, FMCG | Technology & innovation
9 Feb '15 | Technology & innovation
 

Feature stories

27 Mar '15
18 Mar '15
Russian innovation companies step up their efforts in...
10 Mar '15
The manner with which Russian ideas are presented and...
Search (News archive - 18919)
Technology Commercialization
Advertising
Hi-tech Technopark Association of Russia

Latest News

31 Mar '15
Next gen blood-based drug production is slated for...
30 Mar '15
Russian developers are said to have created a smart...
30 Mar '15
Russian wedding start-up Wedvice has received $400k...

Most read stories from last week

30 Mar '15
Russian wedding start-up Wedvice has received $400k...
30 Mar '15
Russian developers are said to have created a smart...
31 Mar '15
Next gen blood-based drug production is slated for...